Related Experiment Video
Updated: Mar 8, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Bariatric Surgery Enhances Splanchnic Vascular Responses in Patients With Type 2 Diabetes
Henri Honka1, Jukka Koffert1,2, Saila Kauhanen3
1Turku PET Centre, University of Turku, Turku, Finland.
Abstract:
Bariatric surgery results in notable weight loss and alleviates hyperglycemia in patients with type 2 diabetes (T2D). We aimed to characterize the vascular effects of a mixed meal and infusion of exogenous glucose-dependent insulinotropic polypeptide (GIP) in the splanchnic region in 10 obese patients with T2D before and after bariatric surgery and in 10 lean control subjects. The experiments were carried out on two separate days. Pancreatic and intestinal blood flow (BF) were measured at baseline, 20 min, and 50 min with 15O-water by using positron emission tomography and MRI. Before surgery, pancreatic and intestinal BF responses to a mixed meal did not differ between obese and lean control subjects. Compared with presurgery, the mixed meal induced a greater increase in plasma glucose, insulin, and GIP concentrations after surgery, which was accompanied by a marked augmentation of pancreatic and intestinal BF responses. GIP infusion decreased pancreatic but increased small intestinal BF similarly in all groups both before and after surgery. Taken together, these results demonstrate that bariatric surgery leads to enhanced splanchnic vascular responses as a likely consequence of rapid glucose appearance and GIP hypersecretion.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Chronic Pancreatitis II: Collaborative Care
Assessment:
Oral Hypoglycemic Agents: Biguanides and Glitazones
Peripheral Artery Disease V: Postoperative Nursing Management

